A Study Comparing the Effects and Safety of Dulaglutide With Glimepiride in Type 2 Diabetes Mellitus

NCT01644500 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

737

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG: Dulaglutide
DRUG: Glimepiride
DRUG: Placebo as Capsules
DRUG: Placebo as SC Injection

Sponsor

Eli Lilly and Company